Home/Pipeline/Ischemic Stroke Device(s)

Ischemic Stroke Device(s)

Ischemic Stroke

Pre-clinicalActive

Key Facts

Indication
Ischemic Stroke
Phase
Pre-clinical
Status
Active
Company

About Infinity Neuro

Infinity Neuro is a pre-revenue, private neurovascular device company founded in 2020, targeting the large and growing stroke intervention market. The company's strategy is built on a leadership team with extensive, proven experience in bringing neurovascular devices from development through regulatory approval and successful commercial launch. While specific pipeline details are not publicly disclosed, the company's focus is on 'next-level' innovative devices for both ischemic (clot retrieval) and hemorrhagic (brain bleed) stroke, indicating a broad approach to the neurovascular space. Its established relationships with key physician and business professionals worldwide are cited as a core asset for future growth.

View full company profile

Therapeutic Areas

Other Ischemic Stroke Drugs

DrugCompanyPhase
itMSCs + itNSCsStemedica Cell TechnologiesResearch
Ischemic Stroke ProgramCHS PharmaPre-clinical
3K3A-APCZZ BiotechPhase 2/3